Novo buys majority stake in BBI Group at $562m-plus enterprise value

Novo Holdings’ investment in BBI is part of its Principal Investments strategy targeting investments in well-established life science companies with leading positions in attractive market segments and strong underlying growth drivers.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this